
Mark Zitter, MBA
Advertisement
Articles by Mark Zitter, MBA
Advertisement
Latest Updated Articles
Defining the Great DebatePublished: August 1st 2004 | Updated:
The Great Debate Part II: Should Managed Care Rely on Cost Sharing to Manage Big-ticket Biologics?Published: April 1st 2006 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
3
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
4
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
5



